- Home
- SLGL
as of 01-05-2026 3:59pm EST
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
| Founded: | 1997 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 117.8M | IPO Year: | 2018 |
| Target Price: | $50.00 | AVG Volume (30 days): | 19.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.02 - $52.26 | Next Earning Date: | 11-20-2025 |
| Revenue: | $18,970,000 | Revenue Growth: | 62.04% |
| Revenue Growth (this year): | 121.82% | Revenue Growth (next year): | -78.96% |
Stock Insider Trading Activity of Sol-Gel Technologies Ltd. (SLGL)
10% Owner
Avg Cost/Share
$42.98
Shares
198
Total Value
$8,510.04
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.92
Shares
2,394
Total Value
$100,347.86
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.99
Shares
22,497
Total Value
$944,743.52
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.99
Shares
35,169
Total Value
$1,476,626.74
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.85
Shares
8,638
Total Value
$361,533.99
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.68
Shares
1,626
Total Value
$67,764.53
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.66
Shares
260
Total Value
$10,832.46
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.15
Shares
1,019
Total Value
$41,935.62
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$40.37
Shares
2,735
Total Value
$110,412.22
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$40.00
Shares
87
Total Value
$3,480.00
Owned After
447,331
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | SLGL | 10% Owner | Jan 5, 2026 | Buy | $42.98 | 198 | $8,510.04 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jan 2, 2026 | Buy | $41.92 | 2,394 | $100,347.86 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 31, 2025 | Buy | $41.99 | 22,497 | $944,743.52 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 30, 2025 | Buy | $41.99 | 35,169 | $1,476,626.74 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 29, 2025 | Buy | $41.85 | 8,638 | $361,533.99 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 26, 2025 | Buy | $41.68 | 1,626 | $67,764.53 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 23, 2025 | Buy | $41.66 | 260 | $10,832.46 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 22, 2025 | Buy | $41.15 | 1,019 | $41,935.62 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 17, 2025 | Buy | $40.37 | 2,735 | $110,412.22 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 12, 2025 | Buy | $40.00 | 87 | $3,480.00 | 447,331 |
Compare SLGL vs Leading Stocks
See how SLGL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SLGL Sol-Gel Technologies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.